West Wealth Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,120
Closed -$534K – 146
2026
Q2
$534K Buy
2,120
+121
+6% +$26K 0.09% 83
2026
Q1
$435K Hold
1,999
– – 0.09% 86
2025
Q4
$457K Buy
1,999
+68
+4% +$15.5K 0.09% 74
2025
Q3
$437K Buy
1,931
+108
+6% +$22K 0.1% 72
2025
Q2
$358K Sell
1,823
-60
-3% -$11.2K 0.09% 74
2025
Q1
$389K Buy
1,883
+38
+2% +$7.39K 0.11% 61
2024
Q4
$328K Buy
1,845
+330
+22% +$60.7K 0.1% 66
2024
Q3
$299K Buy
1,515
+9
+0.6% +$1.68K 0.1% 63
2024
Q2
$258K Buy
1,506
+9
+0.6% +$1.49K 0.09% 70
2024
Q1
$273K Buy
1,497
+9
+0.6% +$1.55K 0.1% 66
2023
Q4
$231K Sell
1,488
-2
-0.1% -$292 0.09% 75
2023
Q3
$222K Buy
+1,490
New +$219K 0.1% 66
2023
Q2
– Sell
-1,557
Closed -$248K – 75
2023
Q1
$248K Sell
1,557
-452
-22% -$69.1K 0.11% 53
2022
Q4
$325K Buy
2,009
+22
+1% +$3.37K 0.16% 47
2022
Q3
$266K Buy
1,987
+29
+1% +$4.16K 0.13% 49
2022
Q2
$299K Buy
1,958
+13
+0.7% +$1.99K 0.14% 47
2022
Q1
$315K Buy
1,945
+6
+0.3% +$872 0.13% 44
2021
Q4
$262K Buy
+1,939
New +$229K 0.1% 46

Other funds holding ABBV

West Wealth Group's ABBV Position: Q3 2026 in Review

West Wealth Group sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 2,120 shares — an estimated $534K sold.

West Wealth Group first reported a position in ABBV in Q4 2021 and held it in 18 quarters. The position peaked at $534K in Q2 2026. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • West Wealth Group reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • West Wealth Group sold 2,120 AbbVie shares in Q3 2026, an estimated $534K.
  • West Wealth Group first reported a position in AbbVie in Q4 2021 and held it in 18 quarters.
  • West Wealth Group's AbbVie position peaked at $534K in Q2 2026.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on West Wealth Group's 13F filing for Q3 2026, filed 14 Oct 2026.